Moonlake Immunotherapeutics (MLTX) PT Raised to $29 at Leerink
Tweet Send to a Friend
Leerink analyst Thomas J. Smith raised the price target on Moonlake Immunotherapeutics (NASDAQ: MLTX) to $29.00 (from $24.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
